BioNTech, founded by Turkish immigrants to Germany, and its US partner Pfizer on Tuesday announced starting of clinical study “to evaluate safety tolerability and immunogenicity of an Omicron-based vaccine candidate.” In a statement, the two companies announced the launching of a clinical study saying that it will be carried out on “healthy adults 18 through...
Latest News:
The highest monthly CAD in the history of the republic
What matters on Tuesday, March 21
What matters on Monday, March 20
Dollar lost its savings instrument edge
Quake-hit cities to get investment support
15% of earthquake victim voters migrated
What matters on Tuesday, March 14
A law specific to Istanbul is a must: Mayor of Istanbul
Share of compensation of employees in the GVA hits a 25-year low
Hunger limit doesn’t fit in wallets; new banknote is needed
Opposition bloc eyes deal to reunite, elevate popular mayors
Central Bank and SFD ink USD 5bn deposit deal
What matters on Monday, March 6
A big slowdown in the rate of interest reduction!
Economy expands by 5.6% in 2022
Mortality statistics rise by tenfold due to COVID-19
What matters on Tuesday, February 28
Central Bank cuts interest rate by 50 basis points
Will earthquake aids open a diplomatic channel?
Home
Ugur Sahin